First domestic experience of vr-intervention in endometriosis

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Endometriosis is a chronic inflammatory disease characterized by the presence of endometriosis-like tissues outside the uterus. This condition may be accompanied by psychosomatic and social discomfort, necessitating further research to understand the various factors that affect its development.

Objective: To present new data on the application of virtual reality (VR) technologies concerning the psychosomatic status of patients with endometriosis and highlight the dynamics of changes in the quality of life of women as a result of this intervention.

Materials and methods: This single-center prospective case series included four female patients diagnosed with endometriosis and/or adenomyosis. This represents the intermediate result of the 4-week VR intervention. The inclusion criteria were age between 18 and 49 years, a confirmed diagnosis of genital endometriosis of various locations through instrumental or histological diagnostic pathways, presence of chronic pelvic pain, absence of extragenital diseases, and consent to participate in the study.

Results: The reduction in anxiety and depression levels, along with decreased pain intensity, was confirmed by the changes in their condition as reported by the patients, coupled with improvements in quality of life observed in the study, indicating the potential for successful integration of virtual reality into multimodal treatment strategies for women with endometriosis.

Conclusion: This is the first domestic study to report the use of a medically supervised VR-solution designed to enhance psycho-emotional status and reduce pain in female patients with chronic pelvic pain associated with endometriosis. We hope that our experience can contribute to further research evaluating the effectiveness of VR-applications in this context and will facilitate comparisons of their effectiveness when combined with standard techniques using exclusively conservative approaches.

Full Text

Restricted Access

About the authors

Sergey A. Levakov

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: levakoff@yandex.ru
ORCID iD: 0000-0002-4591-838X

Dr. Med. Sci., Professor

Russian Federation, Moscow

Tatyana A. Gromova

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: tgromova928@yandex.ru
ORCID iD: 0000-0001-6104-9842

PhD, Teaching Assistant

Russian Federation, Moscow

Nana R. Titova

Clinical Hospital No. 85 of the Federal Medical-Biological Agency of Russia

Email: titova_nana@mail.ru

Deputy Head

Russian Federation, Moscow

Stanislav V. Gribkov

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Author for correspondence.
Email: levakoff@yandex.ru

Head of the Department of Virtual and Augmented Reality

Russian Federation, Moscow

Ioanna J. Managadze

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: ktb1966@mail.ru
ORCID iD: 0000-0001-8745-9372

Student

Russian Federation, Moscow

References

  1. Johnson N.P., Hummelshoj L., Adamson G.D., Keckstein J., Taylor H.S., Abrao M.S. et al.; World Endometriosis Society Sao Paulo Consortium. World Endometriosis Society consensus on the classification of endometriosis. Hum. Reprod. 2017; 32(2): 315-24. https://dx.doi.org/10.1093/humrep/ dew293.
  2. Ferreira A.L.L., Bessa M.M.M., Drezett J., de Abreu L.C. Quality of life of the woman carrier of endometriosis: systematized review. Reprodução Clim. 2016; 31: 48-54. https://dx.doi.org/10.1016/j.recli.2015.12.002.
  3. Geoffron S., Cohen J., Sauvan M., Legendre G., Wattier J.M., Daraï E. et al. Traitement médical de l’endométriose: prise en charge de la douleur et de l’évolution des lésions par traitement hormonal. RPC Endométriose CNGOF-HAS [Endometriosis medical treatment: Hormonal treatment for the management of pain and endometriotic lesions recurrence. CNGOF-HAS Endometriosis Guidelines]. Gynecol. Obstet. Fertil. Senol. 2018; 46(3): 231-47. (in French). https://dx.doi.org/10.1016/j.gofs.2018.02.011.
  4. Legendre G., Delbos L., Hudon E., Chabbert-Buffet N., Geoffron S., Sauvan M. et al. Place des nouveaux traitements médicaux dans l’endométriose douloureuse, RPC Endométriose CNGOF-HAS [New medical treatments for painful endometriosis: CNGOF-HAS Endometriosis Guidelines]. Gynecol. Obstet. Fertil. Senol. 2018; 46(3): 256-63. (in French). https://dx.doi.org/10.1016/ j.gofs.2018.02.009.
  5. Vercellini P., Frattaruolo M.P., Rosati R., Dridi D., Roberto A., Mosconi P. et al. Medical treatment or surgery for colorectal endometriosis? Results of a shared decision-making approach. Hum. Reprod. 2018; 33(2): 202-11. https:// dx.doi.org/10.1093/humrep/dex364.
  6. Vercellini P., Buggio L., Frattaruolo M.P., Borghi A., Dridi D., Somigliana E. Medical treatment of endometriosis-related pain. Best Pract. Res. Clin. Obstet. Gynaecol. 2018; 51: 68-91. https://dx.doi.org/10.1016/ j.bpobgyn.2018.01.015.
  7. Merlot B., Dispersyn G., Husson Z., Chanavaz-Lacheray I., Dennis T., Greco-Vuilloud J. et al. Pain reduction with an immersive digital therapeutic tool in women living with endometriosis-related pelvic pain: randomized controlled trial. J. Med. Internet. Res. 2022; 24(9): e39531. https:// dx.doi.org/10.2196/39531.
  8. Merlot B., Elie V., Périgord A., Husson Z., Jubert A., Chanavaz-Lacheray I. et al. Pain reduction with an immersive digital therapeutic in women living with endometriosis-related pelvic pain: at-home self-administered randomized controlled trial. J. Med. Internet. Res. 2023; 25: e47869. https:// dx.doi.org/10.2196/47869.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Trends. Patient No.1

Download (38KB)
3. Fig. 2. Trends. Patient №2

Download (36KB)
4. Fig. 3. Trends. Patient №3

Download (36KB)
5. Fig. 4. Trends. Patient №4

Download (33KB)

Copyright (c) 2025 Bionika Media